ARCHIVES

Phase III Trial Would Give Clearer Picture of C225 Role

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

March 16, 2007

Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive?

September 28, 2012

Centers Program Needs ‘Innovative Additions’ Such as SPORE Grants

September 20, 1991

In Brief: Senate Confirms Sullivan, Who Fires 100 HHS Political Appointees: Wyngaarden Still On Job

March 10, 1989

Post-Hoc Analysis of ThermoDox Suggests OS Improvement

January 31, 2014

In Brief: Balch, Morton Head SSO; Schantz, Rosen Move To MSK; Old Directs US Branch Of Ludwig Inst.

May 10, 1991